TNF and parasitic infectious disease: Mice that were treated with TNF-depleting antibodies had a higher peak parasitemia (20.5% ± 3.51% vs 9.76% ± 2.98%; P = 0.0457, AUC) and ~40% survival compared to mice in the rat Ig control group (~90% survival) (Fig. 7C).